Unveiling the Potential of 7-Bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one
A crucial pharmaceutical intermediate driving advancements in chronic constipation treatment and beyond.
Get a Quote & SampleProduct Core Value
![7-Bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one](https://www.nbinno.com/webimg/gemini_6881521333608_1753305619.png)
7-Bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one
This compound, identified by CAS No. 439089-27-7, is a vital building block in the complex landscape of pharmaceutical synthesis. Its significance is primarily recognized as an intermediate for Elobixibat, a novel agent designed to combat chronic constipation by stimulating bowel function. Beyond its role in gastrointestinal health, its unique chemical structure, featuring a benzothiazepine scaffold, suggests broader pharmacological potential, including antipsychotic and antidepressant effects through interactions with neurotransmitter receptors. The meticulous chemical synthesis and precise structure of this intermediate are key to developing effective therapeutic solutions.
- Unlock pharmaceutical innovation with this key intermediate for Elobixibat synthesis, a compound crucial for advancing treatments for chronic constipation.
- Investigate the diverse pharmacological potential of benzothiazepine derivatives, with this molecule showing promise in neuropsychiatric drug development.
- Ensure synthesis purity and efficacy; understanding the chemical synthesis using NBS is vital for reliable pharmaceutical intermediate manufacturing.
- Explore the intricate chemical structure of CAS 439089-27-7, a subject of detailed crystallographic analysis and a focus for research into organic chemistry.
Advantages This Product Brings
Streamlined Drug Synthesis
The reliable pharmaceutical intermediate manufacturing of this compound simplifies complex drug synthesis pathways, like that for Elobixibat, reducing development time and costs.
Broad Pharmacological Scope
With potential applications extending to neuropsychiatric drug development, this compound offers versatility, enabling research into various therapeutic areas beyond its primary use.
Structural Integrity for Efficacy
The precise chemical structure of 7-Bromo-3,3-dibutyl-8-methoxy-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one, as confirmed by crystallographic analysis, is fundamental for its efficacy in downstream reactions and drug targeting.
Key Applications
Elobixibat Synthesis
As a critical component in the Elobixibat synthesis pathway, this intermediate directly contributes to the development of novel treatments for chronic constipation, improving patient quality of life.
Pharmaceutical Intermediate Manufacturing
The production of this chemical intermediate is a cornerstone of advanced pharmaceutical intermediate manufacturing, supporting the creation of various complex drug molecules.
Neuropsychiatric Drug Research
The inherent properties of benzothiazepine derivatives make them subjects of interest in neuropsychiatric drug research, where this compound can serve as a foundational element for new therapeutic agents.
Organic Chemistry Research
For those delving into organic chemistry research, the synthesis and structural analysis of molecules like CAS 439089-27-7 offer valuable insights into reaction mechanisms and molecular behavior.